InvestorsHub Logo
Followers 6
Posts 4111
Boards Moderated 0
Alias Born 12/14/2009

Re: itk331 post# 96704

Tuesday, 04/02/2019 6:31:12 PM

Tuesday, April 02, 2019 6:31:12 PM

Post# of 108191
At this point it doesn't matter who the CEO is. This one and the last two capital raises have been on terrible terms because the clincial trial data has not been good enough to convince BP or sophisticated investors that ADXS' platform and science will ever be a commercial success. Biotech is binary, with winners (e.g. Kite) and many more losers like ADXS whose technology doesn't make enough difference over SOC to attract further investment on good terms.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ADXS News